Covaxin Patent Issue: Bharat Biotech to Credit ICMR by Lilu Anderson 23.06.2024 Bharat Biotech admits patent oversight on Covaxin, pledges to include ICMR scientists in new filings to uphold transparency and legal ...
Biotech Stocks: Potential Soar of 120% and 295% by Mark Eisenberg 25.04.2024 Iovance Biotherapeutics has the potential to become a multiproduct company, and even if its stock doesn't soar quickly, it's still ...
Breakthrough Vaccine: One Shot Protects Against All Virus Strains by Lilu Anderson 18.04.2024 Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
BioVaxys Acquires IMV’s Immunotherapy Tech for Growth by John Darbie 13.02.2024 BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...